Literature DB >> 18498377

Cutaneous infection with Leishmania infantum in an infant treated successfully with miltefosine.

Angela Neub1, Dieter Krahl, August Stich, Ulrich Amon.   

Abstract

A two-year-old girl presented with a 20 month history of a facial nodule which had appeared after a vacation on Mallorca. Various topical treatments at other hospitals for the working diagnosis of mastocytoma failed to prevent a slow increase in size and the onset of systemic signs and symptoms. An indurated crusted nodule evolved. Histology, tissue PCR and serologic analysis proved the presence of Leishmania infantum. She was treated with oral miltefosine 10 mg p.o. t.i.d. for 28 days. Regression was apparent after 8 weeks and complete healing after 6 months.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18498377     DOI: 10.1111/j.1610-0387.2008.06779.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  8 in total

Review 1.  Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 2.  An update on pharmacotherapy for leishmaniasis.

Authors:  Shyam Sundar; Jaya Chakravarty
Journal:  Expert Opin Pharmacother       Date:  2014-10-25       Impact factor: 3.889

3.  Kennel dogs as sentinels of Leishmania infantum, Toxoplasma gondii, and Neospora caninum in Majorca Island, Spain.

Authors:  Oscar Cabezón; Javier Millán; Margalida Gomis; Jitender P Dubey; Ezio Ferroglio; Sonia Almería
Journal:  Parasitol Res       Date:  2010-08-06       Impact factor: 2.289

4.  A species-specific approach to the use of non-antimony treatments for cutaneous leishmaniasis.

Authors:  Roshan Ramanathan; Kawsar R Talaat; Daniel P Fedorko; Siddhartha Mahanty; Theodore E Nash
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

5.  Cutaneous leishmaniasis after travel to Cyprus and successful treatment with miltefosine.

Authors:  Wolfgang Poeppl; Julia Walochnik; Tom Pustelnik; Herbert Auer; Gerhard Mooseder
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

6.  Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients.

Authors:  Ayelet Ollech; Michal Solomon; Amir Horev; Shiran Reiss-Huss; Dan Ben-Amitai; Alex Zvulunov; Rivka Friedland; Vered Atar-Snir; Vered Molho-Pessach; Aviv Barzilai; Shoshana Greenberger
Journal:  Acta Derm Venereol       Date:  2020-10-19       Impact factor: 3.875

7.  A Potential New Source of Therapeutic Agents for the Treatment of Mucocutaneous Leishmaniasis: The Essential Oil of Rhaphiodon echinus.

Authors:  Carlos Vinicius Barros Oliveira; Patric Anderson Gomes da Silva; Saulo Relison Tintino; Cathia Cecília Coronel; Maria Celeste Vega Gomez; Mírian Rolón; Francisco Assis Bezerra da Cunha; Maria Flaviana Bezerra Morais-Braga; Henrique Douglas Melo Coutinho; Abolghasem Siyadatpanah; Polrat Wilairatana; Jean Paul Kamdem; Luiz Marivando Barros; Antonia Eliene Duarte; Pedro Silvino Pereira
Journal:  Molecules       Date:  2022-03-27       Impact factor: 4.411

8.  Miltefosine for Mucosal and Complicated Cutaneous Old World Leishmaniasis: A Case Series and Review of the Literature.

Authors:  Vincent Mosimann; Claudia Blazek; Heini Grob; Matthew Chaney; Andreas Neumayr; Johannes Blum
Journal:  Open Forum Infect Dis       Date:  2016-02-01       Impact factor: 3.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.